680 related articles for article (PubMed ID: 15766296)
41. Efficacy and safety of fluvoxamine in body dysmorphic disorder.
Phillips KA; Dwight MM; McElroy SL
J Clin Psychiatry; 1998 Apr; 59(4):165-71. PubMed ID: 9590666
[TBL] [Abstract][Full Text] [Related]
42. Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials.
Gao K; Verduin ML; Kemp DE; Tolliver BK; Ganocy SJ; Elhaj O; Bilali S; Brady KT; Findling RL; Calabrese JR
J Clin Psychiatry; 2008 Jul; 69(7):1057-63. PubMed ID: 18588360
[TBL] [Abstract][Full Text] [Related]
43. Substance use disorders in an obsessive compulsive disorder clinical sample.
Mancebo MC; Grant JE; Pinto A; Eisen JL; Rasmussen SA
J Anxiety Disord; 2009 May; 23(4):429-35. PubMed ID: 18954963
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study.
Toftdahl NG; Nordentoft M; Hjorthøj C
Soc Psychiatry Psychiatr Epidemiol; 2016 Jan; 51(1):129-40. PubMed ID: 26260950
[TBL] [Abstract][Full Text] [Related]
45. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.
Simeon D; Hollander E; Stein DJ; Cohen L; Aronowitz B
Am J Psychiatry; 1995 Aug; 152(8):1207-9. PubMed ID: 7625473
[TBL] [Abstract][Full Text] [Related]
46. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
47. Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.
Wu LT; Blazer DG; Gersing KR; Burchett B; Swartz MS; Mannelli P;
J Psychiatr Res; 2013 Dec; 47(12):1940-8. PubMed ID: 24060266
[TBL] [Abstract][Full Text] [Related]
48. Body dysmorphic disorder and social phobia: cross-sectional and prospective data.
Coles ME; Phillips KA; Menard W; Pagano ME; Fay C; Weisberg RB; Stout RL
Depress Anxiety; 2006; 23(1):26-33. PubMed ID: 16278832
[TBL] [Abstract][Full Text] [Related]
49. Clinical and subclinical body dysmorphic disorder.
Altamura C; Paluello MM; Mundo E; Medda S; Mannu P
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):105-8. PubMed ID: 11697569
[TBL] [Abstract][Full Text] [Related]
50. A prospective pilot study of levetiracetam for body dysmorphic disorder.
Phillips KA; Menard W
CNS Spectr; 2009 May; 14(5):252-60. PubMed ID: 19407724
[TBL] [Abstract][Full Text] [Related]
51. Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study.
Lagerberg TV; Andreassen OA; Ringen PA; Berg AO; Larsson S; Agartz I; Sundet K; Melle I
BMC Psychiatry; 2010 Jan; 10():9. PubMed ID: 20105311
[TBL] [Abstract][Full Text] [Related]
52. Weight concerns in individuals with body dysmorphic disorder.
Kittler JE; Menard W; Phillips KA
Eat Behav; 2007 Jan; 8(1):115-20. PubMed ID: 17174859
[TBL] [Abstract][Full Text] [Related]
53. Severe obsessive-compulsive disorder with and without body dysmorphic disorder: clinical correlates and implications.
Stewart SE; Stack DE; Wilhelm S
Ann Clin Psychiatry; 2008; 20(1):33-8. PubMed ID: 18297584
[TBL] [Abstract][Full Text] [Related]
54. Bipolar obsessive-compulsive disorder and personality disorders.
Maina G; Albert U; Pessina E; Bogetto F
Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
[TBL] [Abstract][Full Text] [Related]
55. Predictors of remission from body dysmorphic disorder: a prospective study.
Phillips KA; Pagano ME; Menard W; Fay C; Stout RL
J Nerv Ment Dis; 2005 Aug; 193(8):564-7. PubMed ID: 16082302
[TBL] [Abstract][Full Text] [Related]
56. Characteristics of 34 adults with psychogenic excoriation.
Arnold LM; McElroy SL; Mutasim DF; Dwight MM; Lamerson CL; Morris EM
J Clin Psychiatry; 1998 Oct; 59(10):509-14. PubMed ID: 9818631
[TBL] [Abstract][Full Text] [Related]
57. Gender similarities and differences in 200 individuals with body dysmorphic disorder.
Phillips KA; Menard W; Fay C
Compr Psychiatry; 2006; 47(2):77-87. PubMed ID: 16490564
[TBL] [Abstract][Full Text] [Related]
58. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa.
Weich L; Pienaar W
Afr J Psychiatry (Johannesbg); 2009 Aug; 12(3):213-7. PubMed ID: 19750250
[TBL] [Abstract][Full Text] [Related]
59. Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics.
Dyl J; Kittler J; Phillips KA; Hunt JI
Child Psychiatry Hum Dev; 2006; 36(4):369-82. PubMed ID: 16741679
[TBL] [Abstract][Full Text] [Related]
60. Comorbid personality disorders and substance use disorders of mentally ill homicide offenders: a structured clinical study on dual and triple diagnoses.
Putkonen A; Kotilainen I; Joyal CC; Tiihonen J
Schizophr Bull; 2004; 30(1):59-72. PubMed ID: 15176762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
